Frankfurt - Delayed Quote EUR

kneat.com, inc. (FOBK.F)

3.6800

-0.1000

(-2.65%)

As of 8:01:39 AM GMT+2. Market Open.

Global Generics Pharma Leader Selects Kneat

LIMERICK, Ireland, April 09, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that a multinational producer of generic pharmaceuticals (“the Company”) has signed a Services Agreement with Kneat to digitalize its drawing management process. Drawing management supports engineering and validation processes by digitalizing and organizing all technical drawings, eliminating paper-based er

GlobeNewswire 12 days ago

KSIOF
High Growth Tech Stocks To Watch In February 2025

As February 2025 unfolds, global markets are grappling with geopolitical tensions and concerns over consumer spending, which have led to a decline in major U.S. stock indices despite initial gains earlier in the week. Amid these uncertainties, investors are closely monitoring high-growth tech stocks as potential opportunities, given their capacity for innovation and resilience in challenging economic climates.

Simply Wall St. last month

KSIOF
Kneat Achieves Record Revenue for Fourth Quarter and Full Year 2024

LIMERICK, Ireland, Feb. 26, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTC: KSIOF) (“Kneat” or the “Company”) a leader in digitizing and automating validation and quality processes, today announced financial results for the three- and twelve-month periods ended December 31, 2024. All dollar amounts are presented in Canadian dollars unless otherwise stated. Total revenue reaches $13.7 million in the fourth quarter, an increase of 40% year over yearFourth-quarter gross profit grew 48% ye

GlobeNewswire last month

KSIOF
Kneat to Announce 2024 Fourth-Quarter and Full-Year Financial Results February 26, 2025

LIMERICK, Ireland, Feb. 24, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTC: KSIOF) (“Kneat” or the “Company”) a leader in digitizing and automating validation and quality processes, announced today that the Company will release its financial results for the quarter ended December 31, 2024, after TSX market close on February 26, 2025. Eddie Ryan, Chief Executive Officer and Hugh Kavanagh, Chief Financial Officer, will host a conference call and Q&A for sell side analysts via webcast on

GlobeNewswire last month

KSIOF
Investing in kneat.com (TSE:KSI) five years ago would have delivered you a 148% gain

When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can...

Simply Wall St. 2 months ago

KSIOF
Global Consumer Products Leader Selects Kneat to Digitize Validation

LIMERICK, Ireland, Feb. 07, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that a multinational consumer food and drink producer (“the Company”) has signed a three-year Master Services Agreement (“MSA”) with Kneat to digitize its validation processes. Headquartered in Europe and operating manufacturing facilities globally, the Company will initially use Kneat for Equipment and Comp

GlobeNewswire 2 months ago

KSIOF
Global Leader in Specialty Therapeutics Selects Kneat to Digitize Validation

LIMERICK, Ireland, Jan. 09, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that a leading global therapeutics company (“the Company”) has signed a three-year Master Services Agreement with Kneat to digitize its validation processes. This European-headquartered Company employs more than 20,000 people and operates in over 100 countries, with more than ten globally dispersed manufactu

GlobeNewswire 3 months ago

KSIOF
kneat.com, inc. (TSE:KSI) Shares Could Be 29% Above Their Intrinsic Value Estimate

Key Insights kneat.com's estimated fair value is CA$4.54 based on 2 Stage Free Cash Flow to Equity kneat.com's CA$5.86...

Simply Wall St. 3 months ago

KSIOF
Global Medical Device Manufacturer Selects Kneat to Digitize Computer System Validation

LIMERICK, Ireland, Dec. 17, 2024 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQC: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that a manufacturer of medical devices and healthcare therapies (“the Company”) has signed a three-year Master Services Agreement with Kneat to streamline its computer system validation process. This US-headquartered Company manufactures in the United States, Latin America and Europe with sales operations in

GlobeNewswire 4 months ago

KSIOF
Is It Too Late To Consider Buying kneat.com, inc. (TSE:KSI)?

kneat.com, inc. ( TSE:KSI ), is not the largest company out there, but it saw a significant share price rise of 30% in...

Simply Wall St. 4 months ago

KSIOF
ALTEN Selects Kneat to Digitize Validation

LIMERICK, Ireland, Nov. 27, 2024 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that it has signed a three-year Master Services Agreement with ALTEN SA, a world leader in Engineering and IT Services. ALTEN will leverage Kneat Gx to digitize its own validation processes and those of its customers within the Life Sciences space. With almost 60,000 employees and operations in more than 30

GlobeNewswire 4 months ago

KSIOF
kneat.com Third Quarter 2024 Earnings: Beats Expectations

kneat.com ( TSE:KSI ) Third Quarter 2024 Results Key Financial Results Revenue: CA$12.8m (up 52% from 3Q 2023). Net...

Simply Wall St. 5 months ago

KSIOF
Kneat Achieves Record Results in Growth and Profitability

Third-quarter Revenue and Gross Profit Growth Accelerate to 52% and 78% RespectivelyLIMERICK, Ireland, Nov. 06, 2024 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI, OTC: KSIOF) (“Kneat” or the “Company”), a leader in digitizing and automating validation and quality processes, today announced financial results for the three-month period ended September 30, 2024. All dollar amounts are presented in Canadian dollars unless otherwise stated. Third-quarter 2024 total revenue reaches $12.8 million, an

GlobeNewswire 5 months ago

KSIOF
Global Medical Devices Manufacturer Selects Kneat to Digitize Validation

LIMERICK, Ireland, Oct. 31, 2024 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTC: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that a global and diverse medical devices manufacturer has signed a three-year Master Services Agreement with Kneat to digitize its validation processes. The Company provides solutions to the pharma, biotech and cosmetic industries, including pharmaceutical primary packaging, drug delivery systems, diagnostic

GlobeNewswire 5 months ago

KSIOF
Kneat to Announce 2024 Third-Quarter Financial Results November 6, 2024

LIMERICK, Ireland, Oct. 30, 2024 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTC: KSIOF) (“Kneat” or the “Company”) a leader in digitizing and automating validation and quality processes, announced today that the Company will release its financial results for the quarter ended September 30, 2024, after TSX market close on November 6, 2024. Eddie Ryan, Chief Executive Officer and Hugh Kavanagh, Chief Financial Officer, will host a conference call and Q&A for sell side analysts via webcast on

GlobeNewswire 5 months ago

KSIOF
Private companies own 13% of kneat.com, inc. (TSE:KSI) shares but retail investors control 58% of the company

Key Insights Significant control over kneat.com by retail investors implies that the general public has more power to...

Simply Wall St. 5 months ago

KSIOF
Kneat Announces Closing of $35.6 Million Bought Deal

Not for distribution to United States newswire services or for dissemination in the United States TORONTO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX:KSI) ("Kneat" or the "Company") announced today the closing of its previously announced bought deal offering (the "Offering") of common shares of the Company (the "Common Shares"). Pursuant to the Offering, the Company issued a total of 7,500,000 Common Shares at a price of $4.75 per Common Share (the “Offering Price”) for gross proceed

GlobeNewswire 6 months ago

KSIOF
Global Pharma Selects Kneat to Digitize Computer System Validation

LIMERICK, Ireland, Oct. 08, 2024 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTC: KSIOF), a leader in digitizing validation and quality processes, is pleased to announce that a global pharmaceutical company has signed a three-year Master Services Agreement with Kneat to digitize its validation processes. Headquartered in Germany with over 11,000 employees across more than a dozen facilities, the company is a trusted maker of household consumer health care brands and generic and specialty pha

GlobeNewswire 6 months ago

KSIOF
Kneat Files Final Short Form Prospectus in Connection with Bought Deal Equity Financing and Obtains Receipt of Final Prospectus

Final Short Form Prospectus is Accessible on SEDAR+Not for distribution to United States newswire services or for dissemination in the United States TORONTO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX:KSI) (“Kneat” or the “Company”) announced today that, in connection with its previously announced “bought deal” equity financing, it has filed a final short form prospectus dated October 7, 2024 (the “Final Prospectus”) with the securities commissions or other similar regulatory authori

GlobeNewswire 6 months ago

KSIOF
Kneat Announces $35.0 Million Bought Deal Public Offering

kneat.com, inc. (TSX: KSI) ("Kneat" or the "Company") is pleased to announce that it has entered into an agreement with a syndicate of investment dealers led by Cormark Securities Inc. (the "Underwriters") pursuant to which the Underwriters have agreed to purchase 7,368,500 common shares (the "Common Shares") from the treasury of the Company, at a price of $4.75 per Common Share (the "Offering Price") and offer them to the public by way of short form prospectus for total gross proceeds of $35,00

CNW Group 6 months ago

KSIOF

Performance Overview

Return	FOBK.F	S&P/TSX Composite index (^GSPTSE)
YTD	-7.07%	-1.38%
1-Year	+44.88%	+11.01%
3-Year	+52.07%	+14.60%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

kneat.com, inc. (FOBK.F)

Global Generics Pharma Leader Selects Kneat

High Growth Tech Stocks To Watch In February 2025

Kneat Achieves Record Revenue for Fourth Quarter and Full Year 2024

Kneat to Announce 2024 Fourth-Quarter and Full-Year Financial Results February 26, 2025

Investing in kneat.com (TSE:KSI) five years ago would have delivered you a 148% gain

Global Consumer Products Leader Selects Kneat to Digitize Validation

Global Leader in Specialty Therapeutics Selects Kneat to Digitize Validation

kneat.com, inc. (TSE:KSI) Shares Could Be 29% Above Their Intrinsic Value Estimate

Global Medical Device Manufacturer Selects Kneat to Digitize Computer System Validation

Is It Too Late To Consider Buying kneat.com, inc. (TSE:KSI)?

ALTEN Selects Kneat to Digitize Validation

kneat.com Third Quarter 2024 Earnings: Beats Expectations

Kneat Achieves Record Results in Growth and Profitability

Global Medical Devices Manufacturer Selects Kneat to Digitize Validation

Kneat to Announce 2024 Third-Quarter Financial Results November 6, 2024

Private companies own 13% of kneat.com, inc. (TSE:KSI) shares but retail investors control 58% of the company

Kneat Announces Closing of $35.6 Million Bought Deal

Global Pharma Selects Kneat to Digitize Computer System Validation

Kneat Files Final Short Form Prospectus in Connection with Bought Deal Equity Financing and Obtains Receipt of Final Prospectus

Kneat Announces $35.0 Million Bought Deal Public Offering

Performance Overview